UK markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,733.50+5.00 (+0.29%)
At close: 07:11PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 70.49B
Enterprise value 84.17B
Trailing P/E 15.89
Forward P/E 11.01
PEG ratio (5-yr expected) 1.16
Price/sales (ttm)2.32
Price/book (mrq)5.09
Enterprise value/revenue 2.74
Enterprise value/EBITDA 10.02

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 318.20%
S&P500 52-week change 322.43%
52-week high 31,743.00
52-week low 31,302.60
50-day moving average 31,661.37
200-day moving average 31,520.09

Share statistics

Avg vol (3-month) 38.23M
Avg vol (10-day) 35.61M
Shares outstanding 54.08B
Implied shares outstanding 64.08B
Float 83.93B
% held by insiders 11.77%
% held by institutions 145.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 43.47%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 30.03%
5-year average dividend yield 44.95
Payout ratio 453.31%
Dividend date 3N/A
Ex-dividend date 416 May 2024
Last split factor 24:5
Last split date 319 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.59%
Operating margin (ttm)37.51%

Management effectiveness

Return on assets (ttm)10.06%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)7.57
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 11.23B
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)1.09
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)6.06B